By Mill Chart
Last update: Nov 28, 2023
Growth investors are on the lookout for stocks displaying robust revenue and EPS growth. In this analysis, we'll assess whether SALESFORCE INC (NYSE:CRM) aligns with growth investing criteria, especially as it consolidates and signals a possible breakout. As always, investors should conduct their own research, but SALESFORCE INC has surfaced on our radar for growth with base formation, warranting further examination.
Every stock receives a Growth Rating from ChartMill, ranging from 0 to 10. This rating assesses various growth aspects, including historical and projected EPS and revenue growth. NYSE:CRM boasts a 8 out of 10:
A critical element of ChartMill's stock evaluation is the Health Rating, which spans from 0 to 10. This rating considers multiple health factors, including liquidity and solvency, both in absolute terms and relative to industry peers. NYSE:CRM has received a 5 out of 10:
ChartMill employs its own Profitability Rating system for stock evaluation. This score, ranging from 0 to 10, is derived from an analysis of diverse profitability metrics and margins. In the case of NYSE:CRM, the assigned 7 is noteworthy for profitability:
Next to the Technical Rating, the Setup Rating of a stock determines to which extend the stock is consolidating. This score also ranges from 0 to 10 and is updated daily. The setup score evaluates various short term technical indicators. For NYSE:CRM this score is currently 7:
Besides having an excellent technical rating, CRM also presents a decent setup pattern. Prices have been consolidating lately and the volatility has been reduced. There is very little resistance above the current price. Another positive sign is the recent Pocket Pivot signal.
More Strong Growth stocks can be found in our Strong Growth screener.
Our latest full fundamental report of CRM contains the most current fundamental analsysis.
Check the latest full technical report of CRM for a complete technical analysis.
This article should in no way be interpreted as advice in any way. The article is based on the observed metrics at the time of writing, but you should always make your own analysis and trade or invest at your own responsibility.
239.31
-3.21 (-1.32%)
Find more stocks in the Stock Screener